Related Experiment Video
Updated: May 30, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
Patricia Udaondo1, Salvador Garcia-Delpech, David Salom
1Nuevo Hospital Universitario y Politecnico La Fe, Valencia, Spain. patyudaondo@hotmail.com
Purpose:
To assess the efficacy of intravitreal Pegaptanib sodium (Macugen(®)) injection in the management of refractory macular edema secondary to branch retinal vein occlusion.
Methods:
This is a prospective, nonrandomized, interventional case series. Five eyes of five patients with macular edema refractory to either bevacizumab or triamcinolone were treated with intravitreal injection of Pegaptanib sodium.
Results:
After three months follow-up, both visual acuity and macular edema, measured by optical coherence tomography and fluorescence angiography, dramatically improved.
Conclusion:
Pegaptanib sodium is a safe and efficacy treatment for macular edema secondary to branch retinal vein occlusion.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment